___________________________________________________________________________ Colorectal Cancer 87. American Society of Colon and Rectal Surgeons. Hereditary Colorectal Cancer. Available at https://fascrs.org/patients/diseases-and- conditions/a-z/hereditary-colorectal-cancer. Last accessed March 7, 2022. 88. Jasperson KW, Tuohy TM, Neklason DW, Burt RW. Hereditary and familial colon cancer. Gastroenterology . 2010;138(6):2044-2058. 89. National Cancer Institute. Genetics of Colorectal Cancer: Health Professional Version. Available at https://www.cancer.gov/types/ colorectal/hp/colorectal-genetics-pdq. Last accessed March 7, 2022. 90. Gala M, Chung DC. Hereditary colon cancer syndromes. Semin Oncol . 2011;38(4):490-499. 91. Pollock J, Welsh JS. Clinical cancer genetics: part I: gastrointestinal. Am J Clin Oncol . 2011;34(3):332-336. 92. Murff HJ, Peterson NB, Greevy R, Zheng W. Impact of patient age on family cancer history. Genet Med . 2006;8(7):438-442. 93. Chen S, Wang W, Lee S, et al. Prediction of germline mutations and cancer risk in the Lynch syndrome. JAMA . 2006;296(12):1479- 1487. 94. Lieberman DA, Rex DK, Winawer SJ, et al. Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the U.S. Multi-Society Task Force on Colorectal Cancer. Gastroenterology . 2012;143(3):844-857. 95. Jang E, Chung DC. Hereditary colon cancer: Lynch syndrome. Gut Liver . 2010;4(2):151-160. 96. Patel SG, Ahnen DJ. Familial colon cancer syndromes: an update of a rapidly evolving field. Curr Gastroenterol Rep . 2012;14(5):428-438. 97. Giardiello FM, Allen JI, Axilbund JE, et al. Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the U.S. Multi-Society Task Force on colorectal cancer. Gastroenterology . 2014;147(2):502-526. 98. Khan O, Blanco A, Conrad P, et al. Performance of Lynch syndrome predictive models in a multi-center U.S. referral population. Am J Gastroenterol . 2011;106(10):1822-1827. 99. Jasperson KW, Vu TM, Schwab AL, et al. Evaluating Lynch syndrome in very early onset colorectal cancer probands without apparent polyposis. Fam Cancer. 2010;9(2):99-107. 100. Boland CR. Evolution of the nomenclature for the hereditary colorectal cancer syndromes. Fam Cancer . 2005;4(3):211-218. 101. Vasen HF, Watson P, Mecklin JP, Lynch HT. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative Group on HNPCC. Gastroenterology . 1999;116(6):1453-1456. 102. Umar A, Boland CR, Terdiman JP, et al. Revised Bethesda guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst . 2004;96(4):261-268. 103. Kastrinos F, Syngal S. Inherited colorectal cancer syndromes. Cancer J . 2011;17(6):405-415. 104. Vasen HF, Blanco I, Aktan-Collan K, et al. Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts. Gut . 2013;62(6):812-823. 105. Parry S, Win AK, Parry B, et al. Metachronous colorectal cancer risk for mismatch repair gene mutation carriers: the advantage of more extensive colon surgery. Gut . 2011;60(7):950-957. 106. Vasen HF, Möslein G, Alonso A, et al. Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer). J Med Genet . 2007;44(6):353-362. 107. Renkonen-Sinisalo L, Seppälä TT, Järvinen HJ, Mecklin JP. Subtotal colectomy for colon cancer reduces the need for subsequent surgery in Lynch syndrome. Dis Colon Rectum . 2017;60(8):792-799. 108. Kim TJ, Kim ER, Hong SN, et al. Survival outcome and risk of metachronous colorectal cancer after surgery in Lynch syndrome. Ann Surg Oncol . 2017;24(4):1085-1092. 109. Rodriguez-Bigas MA, Möeslein G. Surgical treatment of hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome). Fam Cancer . 2013;12(2):295-300. 110. Laken SJ, Petersen GM, Gruber SB, et al. Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC. Nat Genet . 1997;17(1):79-83. 111. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology. Genetic/Familial High-Risk Assessment: Colorectal. Available at https://www.nccn.org/professionals/physician_gls/pdf/genetics_colon.pdf. Last accessed March 7, 2022. 112. Vasen HF, Möslein G, Alonso A, et al. Guidelines for the clinical management of familial adenomatous polyposis (FAP). Gut . 2008;57(5):704-713. 113. Iwama T, Tamura K, Morita T, et al. A clinical overview of familial adenomatous polyposis derived from the database of the Polyposis Registry of Japan. Int J Clin Oncol . 2004;9(4):308-316. 114. Libutti SK, Willett CG, Saltz LB, Levine RA. Cancer of the rectum. In: DeVita VT Jr, Lawrence TS, Rosenberg SA (eds). Cancer: Principles and Practice of Oncology . 11th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2018: 970-996. 115. Shaukat A, Kahi CJ, Burke CA, Rabeneck L, Sauer BG, Rex DK. ACG clinical guidelines: colorectal cancer screening 2021. Am J Gastroenterol . 2021;116(3):458-479. 116. Hampel H. Genetic testing for hereditary colorectal cancer. Surg Oncol Clin N Am . 2009;18(4):687-703. 117. Burt R, Neklason DW. Genetic testing for inherited colon cancer. Gastroenterology . 2005;128(6):1696-1716. 118. Farraye FA, Odze RD, Eaden J, Itzkowitz SH. AGA technical review on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease. Gastroenterology . 2010;138(2):746-774.
Powered by FlippingBook